It is a well reputed UK based company which offers complete healthcare ecosystem which helps patient to increase their drug compliance by revolutionizing healthcare and improving drug-adherence through big data analytics delivered via the blockchain technology. The ultimate goal of this project to reduce health care cost by increasing drug compliance of patients.
This ecosystem includes CuraServe™, CuraData™, and CuraView™.
Impact of Poor Adherence on Healthcare Costs
Poor adherence is a major problem for healthcare system of developing countries and also for developed countries. People don't take medicines as prescribed due to several reasons.
Patient-centered factors -
Demographic Factors: Age, Ethnicity, Gender, Education, Marriage Status
Psychosocial factors: Beliefs, Motivation,Attitude
Patient-prescriber relationship
Health literacy
Patient knowledge
Physical difficulties
Tobacco Smoking or alcohol intake
Forgetfulness
History of good compliance
Therapy-related factors-
Route of administration
Treatment complexity
Duration of the treatment period
Medication side effects
Degree of behavioral change required
Taste of the medication
Requirements for drug storage
Healthcare system factors -
Lack of accessibility
Long waiting time
Difficulty in getting prescriptions filled
Unhappy clinic visits
Social and economic factors -
Inability to take time off work
Cost and Income
Social support
Disease factors -
Disease symptoms
Severity of the disease
The review, titled “The Role of Medication Adherence in the U.S. Healthcare System,” suggests that increased medication adherence is one way to address rising health care costs as the population continues to age. Results from a number of studies included in the review indicate that increased medication adherence improves health outcomes in patients while reducing their use of health care services, such as hospitals, which leads to a lower overall cost of care. In contrast, non-adherence to medication has been found to increase overall health care spending.
Curaizon solution for Poor adherence
CuraServe technology helps ensure that patients take their medicines as prescribed by their doctor. By doing this, they help patients live longer and healthier lives. Also, reduce the health care costs that occur when patients fail to take their medications properly. Also, health care providers can get information about patient adherence and well being.
It is an ERC 20 token which based on Etherium network. It can be used to access medical
adherence data via Curaizon’s™ CuraData™ platform. CuraToken™ holders can access data which utilizes powerful, predictive analytics, AI and big data in the fight against drug non-adherence. You can buy Cura tokens from the ICO with bonuses.
Initial Coin Offering (ICO)
ICO started on 2018/06/08 and conducting successfully. It's among top-rated ICOs of the year
Ticker: CTKN
Platform: Ethereum
Token Type: ERC20
Available for sale: 250,000,000 CTKN (50%)
ICO Price: 1 CTKN = 0.20 USD
Accepting: ETH
Hard cap: 25,000,000 USD
You can buy tokens from this link for a special bonus scheme
https://ico.curaizon.com/users/sign_up
Token Distribution
Roadmap
January 2016-
Curaizon™ begins development of drug-adherence
technologies
Development of CuraServe™ begins in collaboration with
Gateway Technolabs
January 2017-
UK Demonstration
CuraServe™ demonstrated to National Health Service
June 2017 -
CuraServe™ Testng
Internal testng & Review
October 2017 -
CuraServe™ Dashboard CrCreationor patents, providers and health services
November 2017 -
Token Offering Preparation
Offering preparation begins
February 2018 -
Launch CuraData™ Alpha
The first phase of CuraData™ available
June 1st, 2018 -
Token Pre-Sale
50% of tokens go on sale with bonus
June 8th, 2018 -
Public token sale
Remaining tokens are sold in public sale
November 2018 -
Launch CuraData™ Beta
Live integration with Curaizons™ data
February 2019 -
CuraData™ official release
commercialization offering full access to our big data and advanced analytcs
March 2019 -
Curaizon™ completes clinical trials and launches CuraServe™
Curaizon’s adherence technology, CuraServe™, is made
available to natonal health services
April 2019 -
Roll out to key EU, ME & Commonwealth markets
Curaizon™ rolls out its adherence technologies to target
markets, gaining tracton creatng mass data
July 2019 -
CuraData™ platorm experiences huge growth
As the user-base increases, our data dramatcally expands
and matures, providing signifcant growth in value
2020 -
CuraData™ 2.0
Fully integrated and full feature data trading and
collaboraton platorm with patent numbers estmated
90+ million
Team
Good team is a one of the most important things for a successful project. This project is leading by Mr. Nicholas James Rumble as CEO
Mark Nathan - Chief Financial Officer (CFO)
Darran Trute - Chief Technology Officer (CTO)
Luke Lerdal - Chief Data Officer (CDO)
Andrey Verbitsky - Tokenomics Exper
Pencho Gavazov - Director of Business Development
Kristaps Kuhalskis - Creative Director
More Details -
Website: https://curatoken.curaizon.com/
Whitepaper: https://curatoken.curaizon.com/wp-content/themes/curatoken/White_paper.pdf
Lite paper: https://curatoken.curaizon.com/wp-content/themes/curatoken/Lite_paper.pdf
Bitcointalk ANN: https://bitcointalk.org/index.php?topic=4401662.0
Bitcointalk Bounty: https://bitcointalk.org/index.php?topic=4759411.0
Twitter: https://twitter.com/curaizon
Facebook: https://www.facebook.com/curaizonltd/
LinkedIn: https://www.linkedin.com/company/curaizon-ltd/
Telegram group: https://t.me/joinchat/ILiK_Q7VBLOByz_7mMUgsQ
Youtube - https://www.youtube.com/channel/UCjNZcxOvYCQSyyXXYPRrbRQ
AUTHOR: Gambangcity
BITCOINTALK: https://bitcointalk.org/index.php?action=profile;u=1855982
ETH: 0xbd4e6B6E19c55D117badfa5C218Ae03263df6072
Tidak ada komentar:
Posting Komentar